CLINICAL_TRIALS
trial_result
· 2026-01-14
Clinical Trial Update: Hydrus Microstent for Refractory Open-Angle Glaucoma [NA]
Summary
The Hydrus Microstent trial for refractory open-angle glaucoma has completed and posted results on 2026-01-14.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ivantis, Inc. | Conditions: Open-angle Glaucoma | NA | Status: COMPLETED | Results posted: 2026-01-14